Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interferon-beta-1a for Chronic Hepatitis C in Asian Subjects
NCT00249860Phase 3Completed
- Sponsor
- EMD Serono
- Start
- Sep 2002
- Primary completion
- Aug 2005
- Modality
- Cytokines & Interferons
01
Overview
Phase 3, randomised, double-blind trial in hepatitis C (HCV) comparing Interferon-beta-1a with Placebo / Crossover (2 arms). Primary endpoint: Sustained Viral Response at 48 weeks. Started Sep 2002; status: completed.
02
Drugs
interferon beta-1a
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00249860.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00249860.